期刊文献+

选择性5-羟色胺再吸收抑制剂的不良反应及其合理使用 被引量:5

Adverse reactions and rational uses of selective serotonin reuptake inhibitors
原文传递
导出
摘要 选择性5-羟色胺再吸收抑制剂如氟西汀、舍曲林、帕罗西汀、氟伏沙明、西酞普兰等常用于治疗各种因素引起的抑郁症,随着使用人数的逐渐增多,所暴露的不良反应也增多。通过检索国外相关文献,发现该类药物暴露其不良反应有时间先后顺序,主要为最早短暂的效应、持续效应、与其他药物或食物相互作用所产生的效应、延迟效应和停药效应。医护人员和患者应警惕该类药物的迟发和停药不良反应,避免使用与其有不良相互作用的其他药物和食物。 Selective serotonin reuptake inhibitors, such as fluoxetin, sertraline, paroxetine and fluvoxamine, are often used to treat depressant disorder caused by various factors. Their adverse reactions after exposure have been gradually become a problem as user populations increased. By reviewing pertinent foreign literatures, we found that the adverse reactions of selective serotonin reuptake inhibitors were exposed according to time sequence. Namely, the reactions include early but transitory effects, lasted effects, effects caused by interacting with food and other medicines, late onset and withdraw effects. The latter adverse reaction caused by selective serotonin reuptake inhibitors should be alerted by nurses and doctors, and food and the other drug interaction should be avoided.
出处 《中国新药杂志》 CAS CSCD 北大核心 2009年第21期2093-2095,共3页 Chinese Journal of New Drugs
关键词 选择性5-羟色胺再吸收抑制剂 不良反应 不良相互作用 selective serotonin reuptake inhibitors adverse reaction adverse interaction
  • 相关文献

参考文献11

  • 1RASMUSSEN BB, BROSEN K. Is therapeutic drug monitoring a case for optimizing clinical outcome and avoiding interactions of the selective serotonin reuptake inhibitors? [ J ].Ther Drug Monit, 2000, 22(2): 143- 154. 被引量:1
  • 2ROSENBERG R. Current drug treatment. Effects of antidepressive agents in nervous and stress-related disorders [ J]. Ugeskr Laeger, 2001,163(14) :1985 - 1991. 被引量:1
  • 3LOPEZ-MUNOZ F, ALAMO C, RUBIO G,et al. Bibliometric analysis of biomedical publications on SSRI during 1980-2000 [ J ] . Depress Anxiety, 2003,18(2) : 95 - 103. 被引量:1
  • 4ROOSESP, MIYAZAKI M. Pharmacologic treatment of depression in patients with heart disease [ J ]. Psychosom Med, 2005, 67 Suppl 1 : S54 - S57. 被引量:1
  • 5DE-LIMA MS, HOTOPFM. Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence [ J ]. Drug Saf, 2003, 26(1): 55-64. 被引量:1
  • 6FREY R, SCHREINZER D, STIMPFL T, et al. Suicide by antidepressant intoxication identified at autopsy in Vienna from 1991- 1997 : the favourable consequences of the increasing use of SSRIs [J]. Eur Neuropsychopharmacol, 2000, 10(2) : 133 - 142. 被引量:1
  • 7IRELAND RR. Pharmacologic considerations for serotonin reuptake inhibitor use by aviators [ J ]. Aviation Space Environ Med, 2002,73(5) :421 - 429. 被引量:1
  • 8HIEMKE C, HARTTER S. Pharmacokinetics of selective serotonin reuptake inhibitors [ J ] . Pharmacol Ther, 2000, 85 (1):11-28. 被引量:1
  • 9BROSEN K. Some aspects of genetic polymorphism in the biotransformation of antidepressants [ J ] . Therapie, 2004 59 (1): 5-12. 被引量:1
  • 10MASAND PS, GUPTA S. Long-term side effects of newer-generation antidepressants: SSRIS, venlafaxine, nefazodone, bupropion, and mirtazapine [ J] . Ann Clin Psychiatry, 2002, 14 (3) :175 - 182. 被引量:1

同被引文献34

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部